论文部分内容阅读
The title compound C18H22N4O4 was synthesized by the reaction of 3-hydrazine-4-hy- droxy-6-methyl-2(1H)-pyridinones with 2-hydroxy-4-diethylaminobenzaldehyde in ethanol and characteri- zed by IR, 1H NMR and elemental analysis. The single-crystal structure has been determined by X-ray diffraction analysis. The crystal belongs to the triclinic system, space group P1 with a = 10.1930(14), b = 12.5200(17), c = 15.1863(19) ?, α = 96.292(3), β = 96.450(3), γ = 102.443(3)°, V = 1862.6(4) ?3, Z = 4, Mr = 358.40, μ = 0.092 mm-1, D c= 1.278 g/cm3, F(000) = 760 and R = 0.0803. The crystal structure involves intermolcular N–H…O as well as intramolcular O–H…N, O–H…O and N–H…O hydrogen bonds. The title compound shows no antibacterial activity.
The title compound C18H22N4O4 was synthesized by the reaction of 3-hydrazine-4-hy-droxy-6-methyl-2 (1H) -pyridinones with 2-hydroxy-4-diethylaminobenzaldehyde in ethanol and characteri- zed by IR, The single crystal structure has been determined by X-ray diffraction analysis. The crystal belongs to the triclinic system, space group P1 with a = 10.1930 (14), b = 12.5200 (17), c = 15.1863 (19) , α = 96.292 (3), β = 96.450 (3), γ = 102.443 (3) °, V = 1862.6 (4) 3 3, Z = 4, Mr = 358.40, μ = 0.092 mm-1, = 1.278 g / cm3, F (000) = 760 and R = 0.0803. The crystal structure involves intermolcular N-H ... O as well as intramolcular O-H ... N, O-H ... O and N-H ... O hydrogen bonds The title compound shows no antibacterial activity.